Prague, Czechia

Hana Petrickova

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Zentiva, A.s.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hana Petrickova. Retrieved from https://idiyas.com/inventor/hana-petrickova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hana Petrickova: Innovator in Pharmaceutical Formulations

Introduction

Hana Petrickova is a distinguished inventor based in Praha, Czech Republic. She has made significant contributions to the field of pharmaceuticals, particularly in the development of new drug formulations. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Hana holds a patent for "Amorphous forms of risedronate monosodium." This patent involves the monosodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid in new amorphous forms, methods of preparation, and a pharmaceutical formulation. This invention is crucial for improving the efficacy and delivery of medications.

Career Highlights

Hana is currently employed at Zentiva, a.s., where she continues to innovate and contribute to the pharmaceutical industry. Her work at Zentiva has allowed her to collaborate with other talented professionals and push the boundaries of drug development.

Collaborations

Throughout her career, Hana has worked alongside notable colleagues such as Jindrich Richter and Josef Jirman. These collaborations have enriched her research and led to advancements in pharmaceutical formulations.

Conclusion

Hana Petrickova is a remarkable inventor whose work in pharmaceutical formulations has the potential to impact the medical field significantly. Her dedication to innovation and collaboration exemplifies the spirit of advancement in science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…